Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jun 16, 2017
Financial News
Immuron raises $6.1M in follow-on and lists on NASDAQ
...to transfer its listing to NASDAQ from the Pink Sheets. Joseph Gunnar, H.C. Wainwright and
WallachBeth Capital
...
Read More
BioCentury
|
Apr 14, 2017
Financial News
Immuron amends follow-on
...10, Immuron Ltd. (ASX:IMC; Pink:IMROY) amended its follow-on to list its ADSs on NASDAQ adding
WallachBeth Capital
...
Read More
BioCentury
|
Oct 17, 2016
Financial News
AzurRx completes IPO
...Type: IPO Raised: $5.3 million Shares: 960,000 Price: $5.50 Shares after offering: 9.6 million Underwriters:
WallachBeth Capital
...
Read More
BioCentury
|
Oct 10, 2016
Financial News
AzurRx amends IPO
...Type: IPO To be raised: Up to $6.6 million Shares: 1.2 million Price: $5.50 Underwriters:
WallachBeth Capital
...
Read More
BioCentury
|
Sep 12, 2016
Financial News
AzurRx amends IPO
...Type: IPO To be raised: Up to $13.6 million Shares: 1.7 million Price: $6-$8 Underwriters:
WallachBeth Capital
...
Read More
BioCentury
|
Aug 1, 2016
Financial News
AzurRx amends IPO
...Type: IPO To be raised: Up to $15 million Shares: 2.1 million Price: $6-$8 Underwriters:
WallachBeth Capital
...
Read More
BioCentury
|
Jul 18, 2016
Financial News
AzurRx proposes IPO
...2016-07-13 Type: IPO To be raised: Up to $15 million Shares: TBD Price: TBD Underwriters:
WallachBeth Capital
...
Read More
BioCentury
|
May 16, 2016
Financial News
VistaGen completes follow-on
...million Shares: 2.4 million Price: $4.25 Shares after offering: 7.7 million Underwriters: Chardan Capital Markets;
WallachBeth Capital
...
Read More
BioCentury
|
May 9, 2016
Financial News
VistaGen amends follow-on
...raised: Up to $13.9 million Shares: 2.4 million Price prior: $8 Underwriters: Chardan Capital Markets;
WallachBeth Capital
...
Read More
BioCentury
|
Apr 25, 2016
Financial News
VistaGen amends follow-on
...be raised: Up to $13.8 million Shares: TBD Price Prior: $8 Underwriters: Chardan Capital Markets;
WallachBeth Capital
...
Read More
Items per page:
10
1 - 10 of 12
BioCentury
|
Jun 16, 2017
Financial News
Immuron raises $6.1M in follow-on and lists on NASDAQ
...to transfer its listing to NASDAQ from the Pink Sheets. Joseph Gunnar, H.C. Wainwright and
WallachBeth Capital
...
Read More
BioCentury
|
Apr 14, 2017
Financial News
Immuron amends follow-on
...10, Immuron Ltd. (ASX:IMC; Pink:IMROY) amended its follow-on to list its ADSs on NASDAQ adding
WallachBeth Capital
...
Read More
BioCentury
|
Oct 17, 2016
Financial News
AzurRx completes IPO
...Type: IPO Raised: $5.3 million Shares: 960,000 Price: $5.50 Shares after offering: 9.6 million Underwriters:
WallachBeth Capital
...
Read More
BioCentury
|
Oct 10, 2016
Financial News
AzurRx amends IPO
...Type: IPO To be raised: Up to $6.6 million Shares: 1.2 million Price: $5.50 Underwriters:
WallachBeth Capital
...
Read More
BioCentury
|
Sep 12, 2016
Financial News
AzurRx amends IPO
...Type: IPO To be raised: Up to $13.6 million Shares: 1.7 million Price: $6-$8 Underwriters:
WallachBeth Capital
...
Read More
BioCentury
|
Aug 1, 2016
Financial News
AzurRx amends IPO
...Type: IPO To be raised: Up to $15 million Shares: 2.1 million Price: $6-$8 Underwriters:
WallachBeth Capital
...
Read More
BioCentury
|
Jul 18, 2016
Financial News
AzurRx proposes IPO
...2016-07-13 Type: IPO To be raised: Up to $15 million Shares: TBD Price: TBD Underwriters:
WallachBeth Capital
...
Read More
BioCentury
|
May 16, 2016
Financial News
VistaGen completes follow-on
...million Shares: 2.4 million Price: $4.25 Shares after offering: 7.7 million Underwriters: Chardan Capital Markets;
WallachBeth Capital
...
Read More
BioCentury
|
May 9, 2016
Financial News
VistaGen amends follow-on
...raised: Up to $13.9 million Shares: 2.4 million Price prior: $8 Underwriters: Chardan Capital Markets;
WallachBeth Capital
...
Read More
BioCentury
|
Apr 25, 2016
Financial News
VistaGen amends follow-on
...be raised: Up to $13.8 million Shares: TBD Price Prior: $8 Underwriters: Chardan Capital Markets;
WallachBeth Capital
...
Read More
Items per page:
10
1 - 10 of 12
Previous page
Next page